Home/Filings/4/0001764013-24-000048
4//SEC Filing

Butchko Julia G. 4

Accession 0001764013-24-000048

CIK 0001764013other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:29 PM ET

Size

7.5 KB

Accession

0001764013-24-000048

Insider Transaction Report

Form 4
Period: 2024-04-02
Butchko Julia G.
Chief Dev. & Tech. Officer
Transactions
  • Award

    Common Stock

    2024-04-02+54,978462,795 total
  • Award

    Stock Option (right to buy)

    2024-04-02+68,72368,723 total
    Exercise: $30.78Exp: 2034-04-02Common Stock (68,723 underlying)
Footnotes (2)
  • [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 2, 2025, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
  • [F2]The shares underlying the options will vest as to 25% of the shares on April 2, 2025 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001796290

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:29 PM ET
Size
7.5 KB